Efficacy of rifampin-moxifloxacin-metronidazole combination therapy in hidradenitis suppurativa.

Olivier Join-Lambert,H. Coignard,Jean-Philippe Jais,Hélène Guet-Revillet,Sylvain Poirée,Sylvie Fraitag,Vincent Jullien,Florence Ribadeau Dumas,Jacques Thèze,Anne-Sophie Le Guern,Sylvie Behillil,Anne Leflèche,Patrick Berche,Paul-Henri Consigny,Olivier Lortholary,Xavier Nassif,Aude Nassif

Efficacy of rifampin-moxifloxacin-metronidazole combination therapy in hidradenitis suppurativa.

2011

Olivier Join-Lambert
H. Coignard
Jean-Philippe Jais
Hélène Guet-Revillet
Sylvain Poirée
Sylvie Fraitag
Vincent Jullien
Florence Ribadeau Dumas
Jacques Thèze
Anne-Sophie Le Guern
Sylvie Behillil
Anne Leflèche
Patrick Berche
Paul-Henri Consigny
Olivier Lortholary
Xavier Nassif
Aude Nassif

Background: Antibiotics have been shown to improve hidradenitis suppurativa (HS) patients but complete remission is rare using these treatments. Objective: To ass

Keywords:

Hidradenitis suppurativa
Dermatology
Metronidazole
Pathology
Moxifloxacin
Rifampicin
Combination therapy
Adverse effect
Chemotherapy
Antibiotics
Medicine
antibacterial agent

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

102

Citations